(Hypertension. 1999;34:1254.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From I. Physiologisches Institut der Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany.
Correspondence to Dr Heimo Ehmke, I. Physiologisches Institut der Ruprecht-Karls Universität, Im Neuenheimer Feld 326, D-69120 Heidelberg, Germany. E-mail ehmke{at}novsrv1.pio1.uni-heidelberg.de
AbstractThe level of renal blood
flow (RBF) is controlled by opposing vasoconstrictor and vasodilator
influences. In a recent investigation in normotensive dogs, we found
that combined blockade of endothelin type A (ETA) receptors
and angiotensin II formation induces marked increases in
RBF that were much larger than the effects of blocking either system
alone. The aim of the present study was to determine the
contribution of nitric oxide (NO) to this vasodilator response.
Experiments were made in 6 conscious, chronically instrumented dogs
subjected to 5 different experimental treatments on separate days.
Blockade of ETA receptors alone by the selective
antagonist LU 135252 had only minor effects on RBF compared
with time-control experiments. Additional blockade of
angiotensin II formation by
angiotensin-converting enzyme inhibition with
trandolaprilat caused a substantial increase of RBF by
50%. This
vasodilation was entirely suppressed when NO formation was prevented by
inhibition of NO synthase with
NG-nitro-L-arginine methyl ester
HCl. However, when during NO synthase inhibition renal vascular NO
concentrations were clamped at control levels by infusing the NO donor
S-nitroso-N-acetyl-D,L-penicillamine,
the vasodilator response to combined blockade of ETA
receptors and angiotensin II formation was completely
restored (
RBF
60%). These results indicate that the vasodilation
after combined ETA receptor blockade and
angiotensin-converting enzyme inhibition is not mediated by
an increase in NO release but results from the unmasking of the tonic
influence that is normally exerted by constitutively released NO.
Accordingly, the tonic activity of endothelial NO
synthase appears to be of major importance in the
physiological regulation of renal vascular
resistance by determining the vasomotor responses to endothelin and
angiotensin II.
Key Words: endothelin receptors, endothelin nitric oxide renal circulation renin-angiotensin system
This article has been cited by other articles:
![]() |
P. C. Colombo, D. Onat, and H. N. Sabbah Acute heart failure as "acute endothelitis" -- Interaction of fluid overload and endothelial dysfunction Eur J Heart Fail, February 1, 2008; 10(2): 170 - 175. [Full Text] [PDF] |
||||
![]() |
N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Montanari, N. Carra, P. Perinotto, V. Iori, E. Fasoli, A. Biggi, and A. Novarini Renal Hemodynamic Control by Endothelin and Nitric Oxide Under Angiotensin II Blockade in Man Hypertension, February 1, 2002; 39(2): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L.S. Pires, C. Barres, J. Sassard, and C. Julien Renal Blood Flow Dynamics and Arterial Pressure Lability in the Conscious Rat Hypertension, July 1, 2001; 38(1): 147 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just, H. Ehmke, L. Toktomambetova, and H. R. Kirchheim Dynamic characteristics and underlying mechanisms of renal blood flow autoregulation in the conscious dog Am J Physiol Renal Physiol, June 1, 2001; 280(6): F1062 - F1071. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |